- $2.25bn
- $3.13bn
- $2.72bn
Fortrea Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Acelyrin, Endeavour Silver, B2Gold
U.S. STOCKS ON THE MOVE-Viatris, National Fuel Gas, Moderna
U.S. STOCKS ON THE MOVE-Hyatt, Fortrea, China ADRs
Fortrea Holdings Inc reports results for the quarter ended in December - Earnings Summary
Fortrea falls on downbeat forecast, Q4 loss
Fortrea sells enabling services and patient access businesses for up to $345 mln (updated)
Brief: Fortrea Signs Definitive Agreement To Divest Certain Assets To Arsenal Capital Partners for up to $345 Million
Brief: Fortrea Sees FY revenue USD 3,140-3,205 million
Fortrea signs agreement to divest certain assets to Arsenal Capital Partners
Fortrea Holdings Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Fortrea Establishes Industry Partnership With Veeva And Advarra To Streamline Patient And Site Clinical Trial Experience
Brief: Fortrea Holdings Will Continue To Work With Acelyrin To Complete Analysis Of The PSA Trial
U.S. RESEARCH ROUNDUP-Aclaris Therapeutics, Beauty Health Co, Vicarious Surgical
Brief: Fortrea Sees FY revenue USD 3,075-3,130 million
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Activist investor Starboard takes position in Fortrea
Fortrea shares climb as activist investor Starboard discloses stake
Press Digest: Wall Street Journal - Oct 17